Michel Vidaud
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Prenatal diagnosis for neurofibromatosis type 1 and the pitfalls of germline mosaics.
Journal: NPJ genomic medicine
Published: January 24, 2024
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Journal: Genome medicine
Published: January 06, 2024
Droplet Digital PCR for Fast and Accurate Characterization of NF1 Locus Deletions: Confirmation of the Predominant Maternal Origin of Type-1 Deletions.
Journal: The Journal of molecular diagnostics : JMD
Published: August 09, 2023
Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1.
Journal: The British journal of dermatology
Published: April 28, 2023
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Journal: medRxiv : the preprint server for health sciences
Published: November 03, 2022
Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1.
Journal: Human genetics
Published: June 11, 2022
French Genomic Medicine Plan 2025 (PFMG2025): France enters the era of genomic medicine
Journal: La Revue du praticien
Published: February 11, 2022
A Humanized Mouse Strain That Develops Spontaneously Immune-Mediated Diabetes.
Journal: Frontiers in immunology
Published: July 28, 2021
Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: May 31, 2021
Last Updated: 09/26/2026